
Pharmatest offers high quality preclinical efficacy studies in oncology and skeletal diseases. In skeletal diseases our services include “in vitro” bone cell assays and “in vivo” models of osteoporosis, osteoarthritis, and bone safety testing. In oncology our focus is in orthotopic and metastasis models, with special expertise in bone metastases.
Contact
Andrew Heiniluoma
Business Development Director, Pharmatest USA
Email: [email protected]
Phone: 978 340 1028 (USA)
www.pharmatest.com
Itäinen Pitkäkatu 4C
20520 Turku
Finland